Cargando…

Soluble Vascular Cell Adhesion Molecule-1 as an Inflammation-Related Biomarker of Coronary Slow Flow

Background: Coronary slow flow (CSF) is an angiographic entity characterized by delayed coronary opacification with no evident obstructive lesion in the epicardial coronary artery. Several studies have shown that the occurrence and development of CSF may be closely related to inflammation. Soluble v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qing, Zhao, Cuiting, Wang, Yonghuai, Mu, Lixin, Li, Xinxin, Qi, Yiqiu, Yang, Jun, Ma, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860687/ https://www.ncbi.nlm.nih.gov/pubmed/36675472 http://dx.doi.org/10.3390/jcm12020543

Ejemplares similares

LncRNA NEAT1 Promote Inflammatory Responses in Coronary Slow Flow Through Regulating miR-148b-3p/ICAM-1 Axis
por: Zhu, Qing, et al.
Publicado: (2021)

Usefulness of soluble endothelial protein C receptor combined with left ventricular global longitudinal strain for predicting slow coronary flow: A case-control study
por: Wang, Yonghuai, et al.
Publicado: (2022)

Incremental value of three-dimensional echocardiography for evaluating left atrial function in patients with coronary slow flow phenomenon: a case control study
por: Li, Jun, et al.
Publicado: (2020)

Value of exercise stress electrocardiography for stratification of exercise capacity and left ventricular systolic and diastolic function on coronary slow flow: case-control study
por: Wang, Yonghuai, et al.
Publicado: (2019)

Assessment of Left and Right Ventricular Diastolic and Systolic Functions Using Two-Dimensional Speckle-Tracking Echocardiography in Patients with Coronary Slow-Flow Phenomenon
por: Wang, Yonghuai, et al.
Publicado: (2015)

Intercellular Adhesion Molecule-1 K469E and Angiotensinogen T207M Polymorphisms in Coronary Slow Flow
por: Gazi, Emine, et al.
Publicado: (2014)

Long Noncoding RNA AF131217.1 Regulated Coronary Slow Flow-Induced Inflammation Affecting Coronary Slow Flow via KLF4
por: Jiang, Haibing, et al.
Publicado: (2022)

Soluble Vascular Cell Adhesion Molecule and Cardiovascular Disease: An Epidemiological View
por: Yamagishi, Kazumasa, et al.
Publicado: (2017)

Sweroside Protects Against Myocardial Ischemia–Reperfusion Injury by Inhibiting Oxidative Stress and Pyroptosis Partially via Modulation of the Keap1/Nrf2 Axis
por: Li, Jun, et al.
Publicado: (2021)

Predictive value of HMGB1 for atrial fibrillation recurrence after cryoballoon ablation in paroxysmal atrial fibrillation patients
por: Li, Xinxin, et al.
Publicado: (2022)

SOLUBLE INTERCELLULAR ADHESION MOLECULE (SICAM-1) AS A BIOMARKER OF VASCULAR COGNITIVE IMPAIRMENT IN OLDER ADULTS
por: Arenas, Rosalinda Sanchez, et al.
Publicado: (2019)

Adhesion molecule, soluble adhesion molecule, and cytokine levels in patients with severe burns
por: Endo, S, et al.
Publicado: (1998)

Restless leg syndrome and slow coronary flow. Is it inflammation or autonomic nervous system?
por: Tekin, Göknur
Publicado: (2015)

Structural requirements for adhesion of soluble recombinant murine vascular cell adhesion molecule-1 to alpha 4 beta 1
Publicado: (1994)

Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.
por: Velikova, G., et al.
Publicado: (1997)

Coronary slow flow: Benign or ominous?
por: Anwar, Mohammed Omer, et al.
Publicado: (2016)

Coronary slow flow: Benign or ominous?
por: Sadr-Ameli, Mohammad Ali, et al.
Publicado: (2015)

Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder
por: Kameno, Yosuke, et al.
Publicado: (2013)

Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon
por: Dai, Xin-tong, et al.
Publicado: (2022)

Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19
por: Yao, Shifei, et al.
Publicado: (2021)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema
por: Zhu, Dan, et al.
Publicado: (2014)

Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
por: Zhu, Yuan-Ting, et al.
Publicado: (2020)

The relationship between eosinophilia and slow coronary flow
por: Altas, Yakup, et al.
Publicado: (2015)

Coronary slow flow: Electrophysiologic evidence of ischemia?
por: Movahed, M. Reza
Publicado: (2015)

Anxiety and depression relationship with coronary slow flow
por: Elamragy, Ahmed A., et al.
Publicado: (2019)

Salusin beta, atherosclerosis, and coronary slow flow
por: Akıncı, Sinan, et al.
Publicado: (2020)

Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM)
por: Grabmaier, U., et al.
Publicado: (2016)

Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow
por: Emrah, Acar, et al.
Publicado: (2016)

The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon
por: Soylu, Korhan, et al.
Publicado: (2014)

Serum concentrations of soluble adhesion molecules in patients with colorectal cancer.
por: Velikova, G., et al.
Publicado: (1998)

Validation of evaluating left ventricular diastolic function with estimated left atrial volume from anteroposterior diameter
por: Wang, Yonghuai, et al.
Publicado: (2021)

Endothelial function in patients with slow coronary flow and normal coronary angiography
por: Signori, Luis Ulisses, et al.
Publicado: (2012)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Coronary Slow Flow Phenomenon Clinical Findings and Predictors
por: Sanati, Hamidreza, et al.
Publicado: (2016)

Oxidant-Antioxidant balance in patients with coronary slow flow
por: Baysal, Sadettin Selcuk, et al.
Publicado: (2019)

Suspected Brugada Phenocopy Secondary to Coronary Slow Flow
por: Shim, Alicia, et al.
Publicado: (2019)

Slow Coronary Blood Flow: Pathogenesis and Clinical Implications
por: Aparicio, Andrea, et al.
Publicado: (2022)

Long-Term Prognosis in Patients with Coronary Slow Flow
por: Mikaeilvand, Amir, et al.
Publicado: (2022)

Coronary slow flow research: a bibliometric analysis
por: Tong, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1646cdrg9obkm7t6q09rrbp99